Pyloric atresia and Down's syndrome: prenatal double bubble false sign. / Atresia pilórica y síndrome de Down: falso signo de la doble burbuja prenatal.

Pyloric atresia is a rare malformation, with an incidence of 1:100,000 live newborns. Male to female ratio is 1/1. Typically, it is an isolated malformation, with a good prognosis, but 20-40% of cases present epidermolysis bullosa, and to a lesser extent, multiple intestinal atresias. We present the case of a pre-term newborn prenatally diagnosed with polyhydramnios, duodenal atresia with "double bubble" sign, and suspected Down's syndrome, who eventually had pyloric atresia.

La atresia pilórica es una malformación rara, presenta una incidencia de 1:100.000 recién nacidos vivos y la ratio hombre/mujer es de 1/1. Generalmente es una malformación aislada, con buen pronóstico, pero entre el 20-40% de los casos se asocia a epidermólisis bullosa y en menor frecuencia a otras atresias intestinales múltiples. Presentamos un caso de recién nacido pretérmino con atresia pilórica con el diagnóstico prenatal de polihidramnios, atresia duodenal con signo de 'doble burbuja' y sospecha de síndrome de Down.

Atresia pilórica y síndrome de Down: falso signo de la doble burbuja prenatal / Pyloric atresia and Down’s syndrome: prenatal double bubble false sign

La atresia pilórica es una malformación rara, presenta una incidenciade 1:100.000 recién nacidos vivos y la ratio hombre/mujer es de 1/1.Generalmente es una malformación aislada, con buen pronóstico, peroentre el 20-40% de los casos se asocia a epidermólisis bullosa y enmenor frecuencia a otras atresias intestinales múltiples.Presentamos un caso de recién nacido pretérmino con atresia piló-rica con el diagnóstico prenatal de polihidramnios, atresia duodenal consigno de ‘doble burbuja’ y sospecha de síndrome de Down.(AU)

Objective. Pyloric atresia is a rare malformation, with an incidenceof 1:100,000 live newborns. Male to female ratio is 1/1. Typically, itis an isolated malformation, with a good prognosis, but 20-40% ofcases present epidermolysis bullosa, and to a lesser extent, multipleintestinal atresias.We present the case of a pre-term newborn prenatally diagnosedwith polyhydramnios, duodenal atresia with “double bubble” sign, andsuspected Down’s syndrome, who eventually had pyloric atresia.(AU)

[Meconium periorchitis prenatal diagnosis: review of the literature, about 3 cases]. / Periorquitis meconial diagnóstico prenatal: revisión de la literatura, a propósito de 3 casos.

OBJECTIVE: To assess the importance of prenatal ultrasound diagnosis of the fetus carrying meconium periorchitis and its predictive relevance for fetal monitoring and prognosis in the context of acute fetal intestinal disease. MATERIAL AND METHODS: Three male fetuses have been diagnosed of meconium periorchitis in our Unit of Fetal Medicine in the last 5 years. Their prenatal ultrasound diagnoses were: testicular tumor (n=1); Meconium periorchitis with acute fetal intestinal perforation (n=2). Gestational age at diagnosis was 33, 34 and 35 weeks. Ultrasound signs at diagnosis were: Increased size of scrotal zone, with hyperechogenic lesions inside and permanence of peritoneum-vaginal canal; at abdominal zone, echographic signs of intestinal disease with or without meconium peritonitis were found (hyperechogenic lesions, edema of intestinal loops and ascites). All three neonates were assessed postnatally by ultrasound and therapeutic indication. RESULTS: Fetal ultrasound findings influenced both evolution and termination of pregnancy. The diagnosis of meconium periorchitis was confirmed postnatally in all cases: in the 1st case, delivered at term, scrotal tumoral pathology was ruled out and did not require abdominal surgery; the other 2 patients were delivered at the same week of prenatal diagnosis and an inguinal-scrotal surgery with intestinal approach because of meconium peritonitis was performed. No patient underwent orchiectomy, maintaining the teste-epididymal binomial intact. CONCLUSION: Prenatal ultrasound diagnosis of meconium periorchitis requires a strict ultrasound follow-up of the fetus as it is a specific marker of intestinal perforation, which can lead to the termination of pregnancy and avoid appearance of complicated meconium peritonitis.

OBJETIVO: Evaluar la importancia del diagnóstico ecográfico prenatal del feto portador de periorquitis meconial y su relevancia predictiva del seguimiento y pronóstico fetal en el contexto de una enfermedad intestinal fetal aguda. MATERIAL Y METODOS: En los últimos 5 años en la Unidad de Medicina Fetal se han diagnosticado tres fetos varones de periorquitis meconial cuyos diagnósticos ecográficos prenatales fueron: tumor testicular (n=1); y periorquitis meconial con perforación intestinal aguda fetal (n=2). La edad gestacional al diagnóstico fue de 33, 34 y 35 semanas. Los signos ecográficos al diagnóstico fueron: a nivel escrotal, aumento del tamaño, lesiones hiperecogénicas y permanencia del conducto peritoneo-vaginal; a nivel abdominal pueden existir signos ecográficos de enfermedad intestinal con o sin peritonitis meconial (lesiones hiperecogénicas, edemas de asas y ascitis). Los tres neonatos fueron evaluados postnatalmente mediante ecografía comparativa de los hallazgos prenatales e indicación terapéutica. RESULTADOS: Los hallazgos ecográficos fetales influyeron en la evolución y finalización de la gestación. El diagnóstico de periorquitis meconial fue confirmado postnatalmente en los tres casos: en el 1er caso a término, se descartó patología tumoral escrotal y no requirió cirugía abdominal; en los otros dos pacientes se indicó finalizar la gestación tras el diagnóstico prenatal y se realizó cirugía inguino-escrotal y abordaje intestinal por la peritonitis meconial. CONCLUSION: El diagnóstico ecográfico prenatal de periorquitis meconial obliga a un seguimiento ecográfico estricto del feto al ser un marcador específico de perforación intestinal, que puede conllevar la finalización de la gestación y evitar la aparición de una peritonitis meconial complicada.

Periorquitis meconial diagnóstico prenatal: revisión de la literatura, a propósito de 3 casos / Meconium periorchitis prenatal diagnosis: review of the literature, about 3 cases

Objetivo: Evaluar la importancia del diagnóstico ecográfico prenatal del feto portador de periorquitis meconial y su relevancia predictiva del seguimiento y pronóstico fetal en el contexto de una enfermedad intestinal fetal aguda. Material y métodos: En los últimos 5 años en la Unidad de Medicina Fetal se han diagnosticado tres fetos varones de periorquitis meconial cuyos diagnósticos ecográficos prenatales fueron: tumor testicular (n=1); y periorquitis meconial con perforación intestinal aguda fetal (n=2). La edad gestacional al diagnóstico fue de 33, 34 y 35 semanas. Los signos ecográficos al diagnóstico fueron: a nivel escrotal, aumento del tamaño, lesiones hiperecogénicas y permanencia del conducto peritoneo-vaginal; a nivel abdominal pueden existir signos ecográficos de enfermedad intestinal con o sin peritonitis meconial (lesiones hiperecogénicas, edemas de asas y ascitis). Los tres neonatos fueron evaluados postnatalmente mediante ecografía comparativa de los hallazgos prenatales e indicación terapéutica. Resultados: Los hallazgos ecográficos fetales influyeron en la evolución y finalización de la gestación. El diagnóstico de periorquitis meconial fue confirmado postnatalmente en los tres casos: en el 1er caso a término, se descartó patología tumoral escrotal y no requirió cirugía abdominal; en los otros dos pacientes se indicó finalizar la gestación tras el diagnóstico prenatal y se realizó cirugía inguino-escrotal y abordaje intestinal por la peritonitis meconial. Conclusión: El diagnóstico ecográfico prenatal de periorquitis meconial obliga a un seguimiento ecográfico estricto del feto al ser un marcador específico de perforación intestinal, que puede conllevar la finalización de la gestación y evitar la aparición de una peritonitis meconial complicada

Objective: To assess the importance of prenatal ultrasound diagnosis of the fetus carrying meconium periorchitis and its predictive relevance for fetal monitoring and prognosis in the context of acute fetal intestinal disease. Material and methods: Three male fetuses have been diagnosed of meconium periorchitis in our Unit of Fetal Medicine in the last 5 years. Their prenatal ultrasound diagnoses were: testicular tumor (n=1); Meconium periorchitis with acute fetal intestinal perforation (n=2). Gestational age at diagnosis was 33, 34 and 35 weeks. Ultrasound signs at diagnosis were: Increased size of scrotal zone, with hyperechogenic lesions inside and permanence of peritoneum-vaginal canal; at abdominal zone, echographic signs of intestinal disease with or without meconium peritonitis were found (hyperechogenic lesions, edema of intestinal loops and ascites). All three neonates were assessed postnatally by ultrasound and therapeutic indication. Results: Fetal ultrasound findings influenced both evolution and termination of pregnancy. The diagnosis of meconium periorchitis was confirmed postnatally in all cases: in the 1st case, delivered at term, scrotal tumoral pathology was ruled out and did not require abdominal surgery; the other 2 patients were delivered at the same week of prenatal diagnosis and an inguinal-scrotal surgery with intestinal approach because of meconium peritonitis was performed. No patient underwent orchiectomy, maintaining the teste-epididymal binomial intact. Conclusion: Prenatal ultrasound diagnosis of meconium periorchitis requires a strict ultrasound follow-up of the fetus as it is a specific marker of intestinal perforation, which can lead to the termination of pregnancy and avoid appearance of complicated meconium peritonitis

Información, comunicación y trato en un servicio de urgencias: evaluación mediante una encuesta de opinión / Opinion survey on information, communication and treatment in an Emergency Department

Objetivo. Conocer aspectos concretos acerca de la información y la comunicación con los usuarios de los servicios de urgencias hospitalarias y el trato recibido en ellos a través de una encuesta telefónica. Métodos. Estudio prospectivo en 2 servicios de urgencias hospitalarias de Salamanca. Se incluyeron en el estudio 400 pacientes (edad media 56,4 ± 20,5 años; 58,4% mujeres). Se realizó una encuesta telefónica con 19 ítems. Doce de ellos recogían las respuestas en escala tipo Likert, con puntuaciones de 1 (muy mal) a 5 (muy bien). El resto permitían responder «sí» o «no». Resultados. El 86% de los pacientes evaluaron positivamente el trato recibido por los profesionales en general, el 92% el respeto mostrado, el 87% el trato de los médicos y el 71% el trato recibido por enfermería. El 27,5% no recuerda haber recibido información del personal del punto azul (profesionales especialmente capacitados para dar información). Se encontró significación estadística (p = 0,045) en relación a la amabilidad y respeto mostrado por enfermería. La mayoría de los pacientes que fueron ingresados en el área de observación del servicio de urgencias no fueron informados sobre los horarios de visita (p = 0,003). Conclusiones. La percepción del trato recibido por los pacientes es buena, mientras que en relación a la información y comunicación es ostensiblemente mejorable y podría ser evaluada utilizando la encuesta que proponemos, ya que permite detectar y utilizar los puntos débiles de estos aspectos de la asistencia sanitaria como lanzaderas de las iniciativas de implementación (AU)

Objective. To gather specific details about the information, communication, and treatment as regards users of hospital emergency services using a telephone survey, in order to implement improvement measures, if necessary. Methods. A prospective study was conducted in two emergency departments in Salamanca. A total of 400 patients were included in the study (mean age 56.4 ± 20.5 years, 58.4% women). A telephone survey was performed with 19 items, of which 12 required responses on a Likert-type scale, with scores of 1 (very bad) to 5 (very good). The remainder of the questions allowed to answer 'yes' or 'no'. Results. The treatment received by the professionals in general was evaluated positively by 86% of the patients; with 92% reporting they were respectful, 87% were treated by doctors and 71% received treatment from nurses. More than one-quarter (27.5%) did not recall receiving information from blue point staff (personnel specially trained to provide information. Statistical significance (P = .045) was found in relation to the kindness and respect shown by nurses. Most patients that were admitted to the observation area of the emergency department were not informed about the visiting hours (P = .003). Conclusions. Perception of care received by patients is good, while in relation to information and communication it is evidently improvable, and could be assessed using the survey that is proposed in order to detect and use the weaknesses in these aspects of health care as implementation initiatives (AU)

[Opinion survey on information, communication and treatment in an Emergency Department]. / Información, comunicación y trato en un servicio de urgencias: evaluación mediante una encuesta de opinión.

OBJECTIVE: To gather specific details about the information, communication, and treatment as regards users of hospital emergency services using a telephone survey, in order to implement improvement measures, if necessary. METHODS: A prospective study was conducted in two emergency departments in Salamanca. A total of 400 patients were included in the study (mean age 56.4±20.5years, 58.4% women). A telephone survey was performed with 19 items, of which 12 required responses on a Likert-type scale, with scores of 1 (very bad) to 5 (very good). The remainder of the questions allowed to answer "yes" or "no". RESULTS: The treatment received by the professionals in general was evaluated positively by 86% of the patients; with 92% reporting they were respectful, 87% were treated by doctors and 71% received treatment from nurses. More than one-quarter (27.5%) did not recall receiving information from blue point staff (personnel specially trained to provide information. Statistical significance (P=.045) was found in relation to the kindness and respect shown by nurses. Most patients that were admitted to the observation area of the emergency department were not informed about the visiting hours (P=.003). CONCLUSIONS: Perception of care received by patients is good, while in relation to information and communication it is evidently improvable, and could be assessed using the survey that is proposed in order to detect and use the weaknesses in these aspects of health care as implementation initiatives.

Nefroma mesoblástico congénito con hiperecogenicidad medular que simula nefrocalcinosis / Congenital mesoblastic nephroma with medullary hyperechogenicity simulating nephrocalcinosis

El nefroma mesoblástico congénito (NMC) es un tumor raro, siendo el más frecuente a nivel renal en los pacientes menores de 2 meses. Su origen histológico es la estroma renal inmadura, y se distinguen los subtipos clásico, mixto y celular. El tratamiento de elección es quirúrgico y su pronóstico es excelente. Se han descrito casos de NMC asociado a nefrocalcinosis en relación con la hipercalcemia paraneoplásica. Exponemos el caso de un recién nacido que presenta en la ecografía imágenes de hiperecogenicidad medular renal bilateral, similar a una nefrocalcinosis, en el contexto clínico de un NMC(AU)

Congenital mesoblastic nephroma (CMN) is a rare tumour which is the most frequent in the first 2 months of life. Its histological origin is the immature renal stromal cells. There are three histological subtypes: clasic, mixte and cellular. The treatment of choice is surgical and the prognosis is excellent. CMN has been reported associated with nephrocalcinosis in relation to paraneoplasic hypercalcaemia. We report a case of a new born with ultrasound imagen of renal medullary hyperechogenicity simulating nephrocalcinosis in the clinical setting of CNM(AU)

Lessons learned using the insertable robotic effector platform (IREP) for single port access surgery.

This paper presents the preliminary evaluation of a robotic system for single port access surgery. This system may be deployed through a 15-mm incision. It deploys two surgical arms and a third arm manipulating a stereo-vision module that tracks instrument location. The paper presents the design of the robot along with experiments demonstrating the capabilities of this robot. The evaluation includes use of tasks from fundamentals of laparoscopic surgery, evaluation of telemanipulation accuracy, knot tying, and vision tracking of tools.

Bases del manejo clínico de la intoxicación por humo de incendios «Docohumo Madrid 2010» / Basis for the clinical management of fire smoke poisoning «Docohumo Madrid 2010»

La intoxicación por humo es la principal causa de morbimortalidad en los incendios. El humo es una mezcla de partículas carbonáceas suspendidas en aire caliente y gases tóxicos. De todos ellos, el monóxido carbono (CO) y fundamentalmente el ácido cianhídrico (CNH) son los que van a provocar la anoxia tisular. Las manifestaciones clínicas de la intoxicación por humo son variables. Algunas de las manifestaciones potenciales podrían ser: irritación ocular, dolor de garganta, estridor laríngeo, disfagia, esputo carbonáceo, tos, disnea, laringoespasmo, broncoespasmo, síndrome coronario, coma, hipoxemia, acidosis láctica, cianosis y muerte. En la evaluación de estos enfermos la presencia de hollín en nariz, boca o esputo sugiere intoxicación grave. Niveles de lactato superiores a 10mmol/l indican cifras de cianuro mayores de 40micromol/l. La pulsicooximetría ha supuesto un avance importante para el diagnóstico, valoración y seguimiento de estos pacientes. En el tratamiento será indispensable valorar la necesidad de una intubación temprana. La administración de oxígeno al 100% será esencial. Como antídoto para el cianuro, el de primera elección es la hidroxicobalamina. Su administración ha de ser precoz. Los criterios de administración son: paciente que ha inhalado humo (restos de hollín en boca, faringe o esputo) y que tenga alteraciones neurológicas (confusión, coma, agitación, convulsiones) y además presenta una de las siguiente circunstancias: bradipnea, parada respiratoria, parada cardiorrespiratoria, shock, hipotensión, láctato >8mmol/l o acidosis láctica. Lógicamente el resto del manejo será convencional en función de síntomas o complicaciones (AU)ies

Poisoning by smoke is the main cause of morbidity and mortality in fires. Smoke is a mixture of carbonaceous particles suspended in hot air and toxic gases. Of these, carbon monoxide (CO) and primarily hydrocyanic acid (CNH), are those that provoke tissue anoxia. The clinical manifestations of smoke poisoning are variables. Some of the potential manifestations could be: eye irritation, sore throat, laryngeal stridor, dysphagia, carbonaceous sputum, cough, dyspnea, laryngospasm, bronchospasm, coronary syndrome, coma, hypoxemia, lactic acidosis, cyanosis and death. In the assessment of these patients the presence of soot in the nose, mouth or sputum suggests serious poisoning. Lactate levels higher than 10mmol/L indicates levels of cyanide major than 40micromole/L. The pulse co-oximetry has assumed an important step forward for the diagnosis, appraisal and monitoring of these patients. In the treatment it will be essential to assess the need of an early intubation. The administration of oxygen to the 100% will be essential. As an antidote to the cyanide, the first-choice is the hydroxocobalamin. Its administration has to be early. Its administration criteria are: patient who has inhaled smoke (remnants of soot in the mouth, pharynx or sputum) and has neurological disorder (confusion, coma, agitation, seizures) and also presents one of the following circumstances: bradypnea, respiratory arrest, cardiorespiratory arrest, shock, hypotension, lactate >8mmol/L or lactic acidosis. Logically, the rest of the management will be conventional depending on symptoms or complications (AU)

[Basis for the clinical management of fire smoke poisoning "Docohumo Madrid 2010"]. / Bases del manejo clínico de la intoxicación por humo de incendios «Docohumo Madrid 2010¼

Poisoning by smoke is the main cause of morbidity and mortality in fires. Smoke is a mixture of carbonaceous particles suspended in hot air and toxic gases. Of these, carbon monoxide (CO) and primarily hydrocyanic acid (CNH), are those that provoke tissue anoxia. The clinical manifestations of smoke poisoning are variables. Some of the potential manifestations could be: eye irritation, sore throat, laryngeal stridor, dysphagia, carbonaceous sputum, cough, dyspnea, laryngospasm, bronchospasm, coronary syndrome, coma, hypoxemia, lactic acidosis, cyanosis and death. In the assessment of these patients the presence of soot in the nose, mouth or sputum suggests serious poisoning. Lactate levels higher than 10mmol/L indicates levels of cyanide major than 40micromole/L. The pulse co-oximetry has assumed an important step forward for the diagnosis, appraisal and monitoring of these patients. In the treatment it will be essential to assess the need of an early intubation. The administration of oxygen to the 100% will be essential. As an antidote to the cyanide, the first-choice is the hydroxocobalamin. Its administration has to be early. Its administration criteria are: patient who has inhaled smoke (remnants of soot in the mouth, pharynx or sputum) and has neurological disorder (confusion, coma, agitation, seizures) and also presents one of the following circumstances: bradypnea, respiratory arrest, cardiorespiratory arrest, shock, hypotension, lactate ≥8mmol/L or lactic acidosis. Logically, the rest of the management will be conventional depending on symptoms or complications.

Bases para el manejo clínico de la intoxicación por humo de incendios / Fundamentals in the clinical management of intoxication due to smoke inhalation

La intoxicación por humo es la principal causa de morbimortalidad en los incendios. El humo es una mezcla de partículas carbonáceas suspendidas en aire caliente y gases tóxicos. De todos ellos, el monóxido carbono (CO) y fundamentalmente el ácido cianhídrico(CNH), son los que van a provocar la anoxia tisular. Las manifestaciones clínicas de la intoxicación por humo son variables. Algunas de las manifestaciones potenciales podrían ser: irritación ocular, dolor de garganta, estridor laríngeo, disfagia, esputo carbonáceo, tos, disnea, laringoespasmo, broncoespasmo, síndrome coronario, coma, hipoxemia,acidosis láctica, cianosis y muerte. En la evaluación de estos enfermos la presencia de hollín en nariz, boca o esputo sugiere intoxicación grave. Los valores delactato superiores a 10 mmol/L indican cifras de cianuro mayores de 40 micromol/L. Lapulsicooximetría ha supuesto un avance importante para el diagnóstico, valoración y seguimiento de estos pacientes. En el tratamiento será indispensable valorar la necesidad de una intubación temprana. La administración de oxígeno al 100% será esencial. Como antídoto para el cianuro, el de primera elección es la hidroxicobalamina. Su administración ha de ser precoz. Los criterios de administración son: paciente que ha inhalado humo (restos de hollín en boca, faringe o esputo) y que tenga alteraciones neurológicas (confusión, coma, agitación, convulsiones) y que además presenta una de las siguiente circunstancias: bradipnea, parada respiratoria, parada cardiorrespiratoria, shock, hipotensión, lactato 8 mmol/L o acidosis láctica. Logicamente, el resto del manejo será el convencional en función de síntomas o complicaciones (AU)

Intoxication due to smoke inhalation is the main cause of morbidity and mortality from fires. Smoke is a mixture of carbon particles suspended in hot air containing toxic gases. Carbon monoxide (CO) and cyanuric acid are the gases that are mainly responsible for tissue anoxia. The clinical signs of intoxication due to smoke inhalation vary. They may include eye irritation, sore throat, laryngeal stridor, dysphagia, soot in sputum, cough, breathlessness, laryngeal spasm,bronchospasm, coronary syndrome, coma, hypoxemia, lactic acidosis, cyanosis, and death. A finding of soot in the nostrils, mouth or sputum suggests severe intoxication. Lactate dehydrogenase levels over 10 mmol/L are indicative of cyanuric acid levels over 40 mmol/L. Pulse oximetry has represented an important advance for diagnosis, examination, and follow-up in this setting. The possible need for early intubation must be assessed and oxygen administration (at100%) is essential. The treatment of choice for cyanuric acid poisoning is hydroxocobalamin. This antidote must be administered promptly whenever a patient has inhaled smoke (soot in mouth, throat or sputum), shows neurologic signs(confusion, coma, agitation, convulsions), or has any of the following signs: bradypnea, respiratory arrest, cardiac arrest,shock, hypotension, lactate dehydrogenase over 8 mmol/L, or lactic acidosis. There after, management will be dictated by symptoms or complications (AU)

Motion estimation of tagged cardiac magnetic resonance images using variational techniques.

This work presents a new method for motion estimation of tagged cardiac magnetic resonance sequences based on variational techniques. The variational method has been improved by adding a new term in the optical flow equation that incorporates tracking points with high stability of phase. Results were obtained through simulated and real data, and were validated by manual tracking and with respect to a reference state-of-the-art method: harmonic phase imaging (HARP). The error, measured in pixels per frame, obtained with the proposed variational method is one order of magnitude smaller than the one achieved by the reference method, and it requires a lower computational cost.

Organización y disponibilidad de recursos para la asistencia toxicológica en los servicios de urgencias de los hospitales españoles / Organisation and resources availability for toxicological care at the emergency outpatient clinics of the Spanish hospitals

Introducción: La mayoría de los intoxicados agudos acaban siendo asistidos en los Servicios de Urgencias Hospitalarios (SUH), constituyendo este ámbito adecuado para evaluar el tipo de organización, los recursos y la asistencia prestada a estos enfermos. Método: Se envió una encuesta por correo a los SUH de 176 hospitales españoles, la cual constaba de siete apartados: características del hospital, disponibilidad de analítica toxicológica urgente las 24 horas, disponibilidad de un botiquín toxicológico, formación específica de postgrado/continuada, investigación clínica, información toxicológica y calidad asistencial (método preferente de descontaminación digestiva e intervalo eficaz para su aplicación en 3 situaciones clínicas). Resultados: El índice de respuestas fue del 43,7%. El 54,5% de los SUH usaban un test en orina para el diagnóstico analítico rápido. La disponibilidad de analítica cuantitativa de los parámetros útiles para el tratamiento fue del 61,9% en hospitales de nivel III. Sólo el 31,4% de las sustancias del botiquín toxicológico estaban disponibles en el 100% de los hospitales. Los quelantes eran accesibles en el 60% y compuestos de aplicación inmediata variaban según el nivel del Hospital entre el 63 y el 90%. El 72,5% de los médicos habían asistido a algún curso de postgrado, el 25,6% había publicado algún trabajo toxicológico y el 59,5% alguna comunicación a un congreso. Disponían de protocolos de intoxicaciones el 87%. El 94,8% de los centros utilizaban como fuente de información el Servicio de Información Toxicológica ubicado en Madrid. El 86,7% de los SUH señalaron al lavado gástrico como método preferente de descontaminación digestiva. Los intervalos de descontaminación correctamente contestados oscilaron entre el 18,7 y el 38,7%. Conclusiones: Es necesario realizar un consenso sobre analítica toxicológica, dotación mínima de antídotos y tiempo en que deben estar disponibles ambos, en función del nivel asistencial del hospital. También debe valorarse la implantación de programas específicos de formación de postgrado/reciclaje, y la redacción y difusión de guías por parte de las Sociedades Científicas, para evitar actitudes rutinarias en el tratamiento del intoxicado agudo (AU)

Background: Most cases of acute intoxication are finally referred to the Hospital Emergency Outpatient Clinics (HEOC), and this is the adequate environment for assessing the type of organisation, the resources and the care provided to these patients. Methods: A questionnaire was mailed to the HEOCs of 176 Spanish hospitals; the questionnaire encompassed seven areas: characteristics of the hospital, 24-hour availability of emergency toxicologic analysis services, availability of a toxicologic “ready-use box”, soecific postgraduate/continuing training of the personnel, clinical research, toxicologic information and quality of care. Results: The response index was 43.7%. Fifty-four point five per cent of the HEOCs used an urine test for rapid toxicologic diagnosis. Availability of quantitative analysis of parameters useful in therapy was 61.9% at level- III hospitals. Only 31.4% of the substances prescribed for the toxicologic “ready-use box” were immediately available in 100% of the hospitals. Chelating agents were accessible in 60%, and immediate-use compounds availability varied between 63% and 90% in the various hospitals. Seventy-two point five per cent of the physicians had attended some postgraduate course; 25.6% had already published some paper on toxicologic subjects, and 59.5% had presented communications at Meeting. Intoxication management protocols were available in 87%; in 94.8% of the Centres the source for emergency information was the Toxicologic Information Service in Madrid. Eighty-six point seven per cent of the HEOCs named gastric lavage as the preferred method for digestive tract decontamination. The questions regarding the decontamination intervals were correctly answered in 18.7% to 38.7% of the cases. Conclusions: A consensus must be reached regarding toxicologic analyses, minimum antidote availability and the period for availability of both. Furthermore, the implementation of specific postgraduate training/recycling programmes and the Guidelines of Scientific Societies should be considered (AU)

Alteraciones del metabolismo hidrocarbonado y menopausia / Alterations of the hydrocarbonated metabolism and menopause

Un porcentaje considerable de mujeres son diagnosticadas de Diabetes Mellitus 2 tras la menopausia, este hecho puede ser una coincidencia (por el propio proceso de envejecimiento) o bien una consecuencia de la misma (los cambios hormonales ocurridos en este periodo, puden acelerar o precipitar el progreso de un estado pre-diabético no conocido hasta el momento a una diabetes franca). En el presente artículo, revisamos los cambios hormonales que tienen lugar durante el climaterio y la menopausia, su implicación en el desarrollo de la adiposidad abdominal, y la de ésta en la progresión de la resistencia a la insulina, que es el mecanismo fisiopatológico primordial en el desarrollo de la diabetes. Comentamos además la influencia de la terapia hormonal sustitutiva sobre el control diabetológico

After menopause, there is a high`percentage of women diagnosed of type 2 Diabetes Mellitus, this fact can be only a coincidence (by the own process of aging) or a consequence, because the hormonal changes that happened during this period, can accelerate or precipitate the progression of this illness from a pre- diabetic state to a diabetic one. Along this article, we reviewed the hormonal changes that take place during climateric state and menopause and the way they are involved in the development of abdominal adiposity and progression of insulin resistance (the main physiopathological mechanism in the development of type 2 Diabetes Mellitus. We also reviewed the influence of the hormonal replacement therapy on metabolic control

Association of adenylate cyclase with an actin-like protein in the human myometrium.

Regulation of muscle contraction by second messengers such as cAMP and regulation of the adenylate cyclase enzyme by the cytoskeleton have been previously described. However, the physical association of both effector and structural elements is still unknown. In this context, we have co-purified a human myometrial adenylate cyclase with an actin-like protein in a two-step purification protocol. The adenylate cyclase catalytic unit was solubilized with Lubrol-PX, submitted to anionic exchange chromatography and purified about 7-fold. The eluate was applied to a forskolin-agarose column obtaining an adenylate cyclase extract enriched 257-fold (enzymatic activity of 1390 pmol/30 min per mg protein) that co-eluted with a 74.6-kDa protein that possessed the 18-27 amino-acid fragment from the N-terminal region of human actin. Under non-reducing conditions, the apparent molecular weight of this protein decreased to 54 kDa, which has been previously described for arthrin. These results provide the first demonstration of the physical association of human myometrial adenylate cyclase with a cytoskeleton-related protein, supporting the hypothesis that adenylate cyclase is regulated by mechanical stimuli.

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.

The overexpression of angiogenic factors such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and insulin-like growth factors (IGFs) plays a role in the migration and proliferation of endothelial cells in many cancers. Consequently, we investigated the effects of bombesin/gastrin-releasing peptide (GRP) antagonists on the expression of these angiogenic factors, the activities of matrix metalloproteinases (MMPs)-2 and -9, as well as the vascular density in MDA-MB-435 human oestrogen-independent breast cancers. Nude mice bearing orthotopic xenografts of MDA-MB-435 breast cancers were treated with bombesin/GRP antagonists for 6 weeks. Daily administration of 20 microg of RC-3095 or 10 microg of RC-3940-II significantly decreased the weight of MDA-MB-435 cancers by 44 and 53%, respectively. The inhibition of tumour growth was associated with a substantial reduction in the expression of mRNA and protein levels of basic fibroblast growth factor (bFGF), IGF-II and VEGF-A in the tumours. Both bombesin/GRP antagonists significantly decreased the vessel density of the tumours by about 37%, as shown by immunohistochemical detection of vessels on tumour slides. Gelatinolytic activities, detected by zymography, revealed a 33-46% reduction in MMP-9 activity after the treatment with either antagonist. In vitro studies revealed that MDA-MB-435 cells secrete bFGF, IGF-II and VEGF-A, and the secretion of these factors is inhibited by RC-3095 and RC-3940-II. This study demonstrates the antiangiogenic effect of bombesin/GRP antagonists RC-3095 and RC-3940-II, and underscores their possible therapeutic application for treatment of breast cancers.

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.

Some brain tumours, such as glioblastomas express high levels of receptors for bombesin/gastrin releasing peptide. We investigated whether bombesin/gastrin releasing peptide receptors found in glioblastoma cell lines can be utilised for targeting of a cytotoxic bombesin analogue, AN-215 consisting of a potent derivative of doxorubicin, 2-pyrrolino-doxorubicin (AN-201) linked to a bombesin-like peptide carrier. This study reports the effect of AN-215 on the growth of U-87MG human glioblastomas xenografted into nude mice. High affinity binding of AN-215 to U-87MG tumours was characterised by an IC(50) value of 4.0+/-0.1 nM, as determined by radioreceptor assays. mRNA analyses revealed the presence of mRNA for BN receptor subtypes 1 and 2. Treatment with AN-215 significantly (P<0.05) extended tumour doubling time from 4.54+/-0.2 days to 8.18+/-1.8 days and inhibited tumour growth as demonstrated by a 69.6% reduction in final tumour volume (P<0.001) and a 64.6% decrease in tumour weight as compared to controls. Cytotoxic radical AN-201 at the same dose was ineffective. The antitumour effect of AN-215 could be blocked by pretreatment with an excess of a bombesin antagonist, indicating that the action of this cytotoxic analogue is receptor-mediated. Our results suggest that patients with inoperable brain tumours such as malignant gliomas may benefit from targeted chemotherapy based on cytotoxic bombesin analogue AN-215.

Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.

PURPOSE: To evaluate the tumor inhibitory activities of antagonists of growth hormone-releasing hormone (GH-RH) and vasoactive intestinal peptide (VIP) in UCI-107 human ovarian cancer model, and to investigate the role of the insulin-like growth factor (IGF) system in the response. METHODS: In the present study we investigated the effects of GH-RH antagonist JV-1-36 and VIP antagonist JV-1-52, on the growth and tumorigenicity of UCI-107 ovarian cell carcinoma xenografted into nude mice. Studies on the effects of hGH-RH(1-29)NH2, IGF-I, IGF-II, JV-1-36, and JV-1-52 on the proliferation of UCI-107 cells cultured in vitro were also performed. RESULTS: After 22 days of therapy with JV-1-36 or JV-1-52 at the dose of 20 microg/day, the final volume of UCI-107 tumors was significantly (P<0.05) decreased by 50.5% and 56%, respectively, compared to controls. The concentration of IGF-II in tumors was reduced by 66% in the JV-1-36-treated group and by 62% in the group given JV-1-52 (both P < 0.05). Exposure in vitro to 1 microM concentrations of JV-1-36 or JV-1-52 for 24 h decreased the tumorigenicity of UCI-107 cells in nude mice. All ten mice injected with cells treated with medium alone developed tumors within 23 days after cell inoculation, while only eight of ten and four of ten mice injected with cells exposed to JV-1-36 or JV-1-52, respectively, had tumors. In vitro exposure of UCI-107 cells to 5-35 ng/ml IGF-II produced a significant suppression in the rate of cell proliferation (P < 0.01). CONCLUSION: Our results suggest that GH-RH and VIP antagonists inhibit the growth of UCI-107 ovarian cell carcinoma by mechanisms that appear to involve direct effects on the cancer cells.

Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness.

Receptors for luteinizing hormone-releasing hormone (LHRH), expressed by ovarian cancers, can be used for targeting chemotherapeutic compounds more selectively to these tumors. We investigated the effects of cytotoxic LHRH analog AN-152, consisting of doxorubicin (DOX)-14-O-hemiglutarate linked to the epsilon-amino group of [D-Lys6]LHRH, on the growth of LHRH receptor-positive ES-2 human ovarian cancer line xenografted into nude mice. A single injection of AN-152, at a dose of 345 nmol/20 g body weight, caused a 34.5% reduction (P<0.05) in tumor growth after 28 days, while its cytotoxic moiety DOX was inactive at the same dose. Since the overexpression of certain growth factors and/or their receptors, such as vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR) and HER-2/neu, as well as various oncogenes like c-fos and c-jun, is associated with unfavorable prognosis and contributes to progressive growth of ovarian carcinomas, their mRNA levels were analyzed by RT-PCR. Treatment with AN-152 significantly (P<0.05) reduced the expression of EGFR, VEGF, c-fos and c-jun, to 49%, 48%, 55% and 58% respectively, compared to controls. HER-2/neu mRNA expression was also decreased to non-detectable levels. Conversely, DOX decreased non-significantly the expression levels for EGFR by 32%, VEGF 35%, both c-fos and c-jun approximately 20% and HER-2/neu by only 15%. In conclusion, cytotoxic LHRH analog AN-152 could be considered for chemotherapy of ovarian cancers expressing LHRH receptors.

Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression.

OBJECTIVE: To determine the expression pattern of certain metalloproteinases (MMPs) known to be involved in the degradation of the extracellular matrix in cultured fibroblasts from the transversalis fascia (TF) of patients with inguinal hernia. SUMMARY BACKGROUND DATA: Inguinal hernia is a common pathology, the cause of which remains unknown. It is, however, clear that the TF is one of the anatomical structures that may impede the formation of hernias, and particularly the direct type of hernia. In previous studies the authors found enhanced MMP-2 expression in TF specimens in vivo. The persistence of increased expression in cultured fibroblasts might support the idea of a genetic defect as the cause for this pathology. METHODS: Fibroblasts from the TF of patients with direct and indirect inguinal hernia were cultured and compared with those obtained from control TF in terms of MMP (MMP-2 and MMP-9) expression. RESULTS: Significant active MMP-2 expression was shown by TF fibroblasts from young patients with direct hernias. These findings were confirmed by immunosorbent assay, immunoblotting, and zymography of the fibroblast culture media. No MMP-9 expression was detected. CONCLUSION: These results indicate that MMP-2 may be involved in the TF matrix degradative process in patients with direct hernia. The persistence of changes in MMP-2 levels in the cell cultures appears to suggest a genetic defect or irreversible change as the origin of this pathology rather than environmental factors, which may later participate in the development of the hernial process.